This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly June 17, 2025 by Projesh Kar Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company. Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Like this:Like Loading... Related Share this content: Projesh Kar I am a passionate blogger with extensive experience in web design. As a seasoned YouTube SEO expert, I have helped numerous creators optimize their content for maximum visibility. Contact